Skip to main content
. Author manuscript; available in PMC: 2024 Jul 5.
Published in final edited form as: Lancet Oncol. 2023 Aug;24(8):925–935. doi: 10.1016/S1470-2045(23)00275-9

Figure 2: Confirmed responses across tumour types and FGFRalt.

Figure 2:

Only tumour types with at least one complete or partial response are shown. The objective response rate and disease control rate were equivalent for the salivary gland tumour type. alt=alterations. DCR=disease control rate. NSCLC=non-small cell lung cancer. ORR=objective response rate.